Nicotinamide Riboside-Conditioned Microbiota Deflects High-Fat Diet-Induced Weight Gain in Mice
Authors:
Open Access
- 22 February 2022
- journal article
- research article
- Published by American Society for Microbiology in mSystems
- Vol. 7 (1) , e0023021
Abstract
With obesity and type 2 diabetes (T2D) at epidemic levels, we need to understand the complex nature of these diseases to design better therapeutics. The underlying causes of both obesity and T2D are complex, but both are thought to develop, in part, based on contributions from the gut microbiota.Keywords
Funding Information
- HHS | National Institutes of Health (HL134850, HL084207)
- American Heart Association (18EIA33890055)
- HHS | National Institutes of Health (AI108255)
This publication has 81 references indexed in Scilit:
- Body Adiposity Index versus Body Mass Index and Other Anthropometric Traits as Correlates of Cardiometabolic Risk FactorsPLOS ONE, 2013
- The NAD+ Precursor Nicotinamide Riboside Enhances Oxidative Metabolism and Protects against High-Fat Diet-Induced ObesityCell Metabolism, 2012
- Fast gapped-read alignment with Bowtie 2Nature Methods, 2012
- The Sequence Alignment/Map format and SAMtoolsBioinformatics, 2009
- Diet-Induced Obesity Is Linked to Marked but Reversible Alterations in the Mouse Distal Gut MicrobiomeCell Host & Microbe, 2008
- Transcriptional regulation of NAD metabolism in bacteria: genomic reconstruction of NiaR (YrxA) regulonNucleic Acids Research, 2008
- Mechanisms underlying the resistance to diet-induced obesity in germ-free miceProceedings of the National Academy of Sciences, 2007
- An obesity-associated gut microbiome with increased capacity for energy harvestNature, 2006
- The gut flora as a forgotten organEMBO Reports, 2006
- Obesity alters gut microbial ecologyProceedings of the National Academy of Sciences, 2005